Materials and Methods Bacterial Strains Community-acquired Methicillin- Resistant Staphylococcus Aureus Carrying Panton-valentine Leukocidin Genes: Worldwide Emergence

cillin-resistant Staphylococcus aureus (MRSA) have been reported worldwide. We assessed whether any common genetic markers existed among 117 CA-MRSA isolates Western Samoa by performing polymerase chain reaction for 24 virulence factors and the methicillin-resistance determinant. The genetic background of the strain was analyzed by pulsed-field gel electrophoresis (PFGE) and multi-locus sequence typing (MLST). The CA-MRSA strains shared a type IV SCCmec cassette and the Panton-Valentine leukocidin locus, whereas the distribution of the other toxin genes was quite specific to the strains from each continent. PFGE and MLST analysis indicated distinct genetic backgrounds associated with each geographic origin, although predominantly restricted to the agr3 background. Within each continent, the genetic background of CA-MRSA strains did not correspond to that of the hospital-acquired MRSA. M ethicillin-resistant Staphylococcus aureus (MRSA) are identified as nosocomial pathogens throughout the world (1). Established risk factors for MRSA infection include recent hospitalization or surgery, residence in a long-term–care facility, dialysis, and indwelling percuta-neous medical devices and catheters. Recently, however, cases of MRSA have been documented in healthy community dwelling persons without established risk factors for MRSA acquisition. Because they are apparently acquired in the community, these infections are referred to as community acquired (CA)-MRSA (2). CA-MRSA infections have been reported in North America, Europe, Australia, and New Zealand (3–5). The recent genomic sequence of a CA-MRSA isolate (6) indicated the presence not only of a novel smaller variant of the methicillin-resistance locus (SCCmec IVa, according to Baba et al. designation [6]), but also that of the locus for the Panton-Valentine leuko-cidin (PVL). The PVL locus is carried on a bacteriophage and is present in only a small percentage of S. aureus isolates from France, where this locus is associated with skin infections, and occasionally, severe necrotizing pneumonia (7,8). In a recent study, we found that CA-MRSA infections in France are caused by a single clone producing the PVL (3). Analysis of a set of CA-MRSA strains from the United States and Australia confirmed the presence of SCCmec IVa in most of them, and genetic comparison of the CA-MRSA by multi-locus sequence typing (MLST) indicated that they belonged to five clonal complexes, two of which predominated (4). This finding suggested that CA-MRSA have arisen from diverse genetic backgrounds rather than the worldwide spread of a single clone (4). The aim of this study was to determine whether the PVL gene represents a stable marker of the CA-MRSA strains …

[1]  G. Nimmo,et al.  Emergence of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) infection in Queensland, Australia. , 2003, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  G. Nimmo,et al.  Community‐acquired MRSA bacteraemia: four additional cases including one associated with severe pneumonia , 2003, The Medical journal of Australia.

[3]  G. Cook,et al.  Phenotypic and molecular characterization of community occurring, Western Samoan phage pattern methicillin-resistant Staphylococcus aureus. , 2002, The Journal of antimicrobial chemotherapy.

[4]  John D. Turnidge,et al.  Dissemination of New Methicillin-Resistant Staphylococcus aureus Clones in the Community , 2002, Journal of Clinical Microbiology.

[5]  F. Vandenesch,et al.  Community-acquired methicillin-resistant Staphylococcus aureus infections in France: emergence of a single clone that produces Panton-Valentine leukocidin. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  D. Oliveira,et al.  Multiplex PCR Strategy for Rapid Identification of Structural Types and Variants of the mec Element in Methicillin-Resistant Staphylococcus aureus , 2002, Antimicrobial Agents and Chemotherapy.

[7]  Y. Nagai,et al.  Genome and virulence determinants of high virulence community-acquired MRSA , 2002, The Lancet.

[8]  P. Vanhems,et al.  Association between Staphylococcus aureus strains carrying gene for Panton-Valentine leukocidin and highly lethal necrotising pneumonia in young immunocompetent patients , 2002, The Lancet.

[9]  Jean Thioulouse,et al.  Relationships between Staphylococcus aureus Genetic Background, Virulence Factors, agr Groups (Alleles), and Human Disease , 2002, Infection and Immunity.

[10]  Amy V. Groom,et al.  Epidemiology and clonality of community-acquired methicillin-resistant Staphylococcus aureus in Minnesota, 1996-1998. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  B. Jalaludin,et al.  Non‐multiresistant and multiresistant methicillin‐resistant Staphylococcus aureus in community‐acquired infections , 2001, The Medical journal of Australia.

[12]  R N Jones,et al.  Survey of infections due to Staphylococcus species: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, Latin America, Europe, and the Western Pacific region for the SENTRY Antimicrobial Surveillance Program, 1997-1999. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[13]  F. Vandenesch,et al.  egc, A Highly Prevalent Operon of Enterotoxin Gene, Forms a Putative Nursery of Superantigens in Staphylococcus aureus , 2001, The Journal of Immunology.

[14]  G. Nimmo,et al.  Community Acquisition of Gentamicin-Sensitive Methicillin-Resistant Staphylococcus aureus in Southeast Queensland, Australia , 2000, Journal of Clinical Microbiology.

[15]  F. Vandenesch,et al.  Involvement of Panton-Valentine leukocidin-producing Staphylococcus aureus in primary skin infections and pneumonia. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  R. Daum Community-acquired methicillin-resistant staphylococcus aureus infections. , 1998, The Pediatric infectious disease journal.

[17]  D H Persing,et al.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing , 1995, Journal of clinical microbiology.

[18]  R. Goering,et al.  Rapid method for epidemiological evaluation of gram-positive cocci by field inversion gel electrophoresis , 1992, Journal of clinical microbiology.

[19]  M. Sugai,et al.  Molecular cloning and sequencing of the epidermal cell differentiation inhibitor gene from Staphylococcus aureus. , 1991, Biochemical and biophysical research communications.

[20]  A. Tomasz,et al.  The evolution of pandemic clones of methicillin-resistant Staphylococcus aureus: identification of two ancestral genetic backgrounds and the associated mec elements. , 2001, Microbial drug resistance.

[21]  B. Spratt,et al.  Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. , 2000, Journal of clinical microbiology.

[22]  I. Gosbell,et al.  Community-acquired meticillin-resistant Staphylococcus aureus in Australia. Australian Group on Antimicrobial Resistance. , 1998, Lancet.

[23]  Statement 1996 CA-SFM Zone sizes and MIC breakpoints for non-fastidious organisms. , 1996, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.